26 related articles for article (PubMed ID: 27390016)
21. In vitro characterisation of the anti-intravasative properties of the marine product heteronemin.
Kopf S; Viola K; Atanasov AG; Jarukamjorn K; Rarova L; Kretschy N; Teichmann M; Vonach C; Saiko P; Giessrigl B; Huttary N; Raab I; Krieger S; Schumacher M; Diederich M; Strnad M; de Martin R; Szekeres T; Jäger W; Dirsch VM; Mikulits W; Grusch M; Dolznig H; Krupitza G
Arch Toxicol; 2013 Oct; 87(10):1851-61. PubMed ID: 23543012
[TBL] [Abstract][Full Text] [Related]
22. NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells.
Vonach C; Viola K; Giessrigl B; Huttary N; Raab I; Kalt R; Krieger S; Vo TP; Madlener S; Bauer S; Marian B; Hämmerle M; Kretschy N; Teichmann M; Hantusch B; Stary S; Unger C; Seelinger M; Eger A; Mader R; Jäger W; Schmidt W; Grusch M; Dolznig H; Mikulits W; Krupitza G
Br J Cancer; 2011 Jul; 105(2):263-71. PubMed ID: 21629247
[TBL] [Abstract][Full Text] [Related]
23. NF-κB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro.
Nguyen CH; Senfter D; Basilio J; Holzner S; Stadler S; Krieger S; Huttary N; Milovanovic D; Viola K; Simonitsch-Klupp I; Jäger W; de Martin R; Krupitza G
Oncotarget; 2015 Nov; 6(36):39262-75. PubMed ID: 26513020
[TBL] [Abstract][Full Text] [Related]
24. 12(S)-HETE increases intracellular Ca(2+) in lymph-endothelial cells disrupting their barrier function in vitro; stabilization by clinical drugs impairing calcium supply.
Nguyen CH; Brenner S; Huttary N; Li Y; Atanasov AG; Dirsch VM; Holzner S; Stadler S; Riha J; Krieger S; Milovanovic D; Fristiohardy A; Simonitsch-Klupp I; Dolznig H; Saiko P; Szekeres T; Giessrigl B; Jäger W; Krupitza G
Cancer Lett; 2016 Sep; 380(1):174-83. PubMed ID: 27390016
[TBL] [Abstract][Full Text] [Related]
25. The current status and perspectives regarding the clinical implication of intracellular calcium in breast cancer.
Tajbakhsh A; Pasdar A; Rezaee M; Fazeli M; Soleimanpour S; Hassanian SM; FarshchiyanYazdi Z; Younesi Rad T; Ferns GA; Avan A
J Cell Physiol; 2018 Aug; 233(8):5623-5641. PubMed ID: 29150934
[TBL] [Abstract][Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
